The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-LAG-3 antibody LBL-007 in combination with toripalimab in patients with unresectable or metastatic melanoma: A phase Ⅰ, open-label, multicenter, dose escalation/expansion study.
 
Xue Bai
Other Relationship - Bristol-Myers Squibb
 
Mei Li
No Relationships to Disclose
 
Xingxiang Pu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Jing Chen
No Relationships to Disclose
 
Yu Jiang
No Relationships to Disclose
 
Xue Chen
No Relationships to Disclose
 
Jingjing Liu
No Relationships to Disclose
 
Li Fan
No Relationships to Disclose
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere
 
Lu Si
Honoraria - MSD; Novartis; Oriengene; Roche China; Shanghai Junshi Biosciences